dsm-firmenich and Boncha Bio partners to advance nutraceuticals with candy-capsule technology

The partnership aims to redefine the dietary supplement landscape by introducing market-ready candyceuticals that meld sensory delight with health benefits

In a landmark development, Boncha Bio is elated to announce a strategic partnership in Asia with dsm-firmenich, a global innovator in nutrition, health, and beauty. This groundbreaking partnership was ceremoniously inked on September 21st at the Vitafoods Asia 2023 exhibition in Bangkok, Thailand. The partnership aims to redefine the dietary supplement landscape by introducing market-ready candyceuticals that meld sensory delight with health benefits.

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. Through this partnership, dsm-firmenich has secured exclusive distribution rights for Boncha Bio’s candyceuticals in the key markets of Japan and South Korea as Market-Ready-Solutions (MRS) under the Health, Nutrition and Care business unit in Asia.

The two companies have worked closely on integrating dsm-firmenich’s high-quality premix with Boncha Bio’s candyceutical technology in the creation of the NutriBurst product line, a soft-chew candy capsule form with central filling. dsm-firmenich made its formal debut of the MRS candy capsule line to its global customers at the Vitafoods Asia 2023 Exhibition.

Read Previous

FAO Food Outlook predicts declining international trade in some basic foodstuffs

Read Next

GrubMarket launches Farm-GPT AI product for food supply chain

Leave a Reply